Cargando…

Defining the minimum inhibitory concentration of 22 rifamycins in iron limited, physiologic medium against Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae clinical isolates

Recently, we reported rifabutin hyper-activity against Acinetobacter baumannii. We sought to characterize if any additional rifamycins (n = 22) would also display hyper-activity when tested in iron-limited media against A. baumannii, K. pneumoniae, and E. coli. MICs were determined against represent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Peggy, Alletto, Francesco, Lee, Bosul, Burk, Elizabeth, Martinez, Jasmine, Prati, Fabio, Caselli, Emilia, Spellberg, Brad, Luna, Brian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10263351/ https://www.ncbi.nlm.nih.gov/pubmed/37310985 http://dx.doi.org/10.1371/journal.pone.0287102

Ejemplares similares

In Vitro Activity of Rifabutin and Rifampin against Antibiotic-Resistant Acinetobacter baumannii, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Klebsiella pneumoniae
por: Lee, Bosul, et al.
Publicado: (2021)

Synergistic Rifabutin and Colistin Reduce Emergence of Resistance When Treating Acinetobacter baumannii
por: Cheng, Jiaqi, et al.
Publicado: (2021)

Natural history of Acinetobacter baumannii infection in mice
por: Luna, Brian M., et al.
Publicado: (2019)

Horizontal Gene Transfer of Antibiotic Resistance from Acinetobacter baylyi to Escherichia coli on Lettuce and Subsequent Antibiotic Resistance Transmission to the Gut Microbiome
por: Maeusli, Marlène, et al.
Publicado: (2020)

971. The Role of Inflammation and Innate Effectors in Passive Immunization for Acinetobacter baumannii Infections
por: Nielsen, Travis B, et al.
Publicado: (2019)

Cryopreservation of virulent Acinetobacter baumannii to reduce variability of in vivo studies
por: Nielsen, Travis B., et al.
Publicado: (2015)

Sub-minimum inhibitory concentrations of colistin and polymyxin B promote Acinetobacter baumannii biofilm formation
por: Sato, Yoshinori, et al.
Publicado: (2018)

Antimicrobial Susceptibility Testing Performed in RPMI 1640 Reveals Azithromycin Efficacy against Carbapenem-Resistant Acinetobacter baumannii and Predicts In Vivo Outcomes in Galleria mellonella
por: Miller, Sarah, et al.
Publicado: (2022)

Capsule carbohydrate structure determines virulence in Acinetobacter baumannii
por: Talyansky, Yuli, et al.
Publicado: (2021)

Biochemical and Structural Analysis of Inhibitors Targeting the ADC-7 Cephalosporinase of Acinetobacter baumannii
por: Powers, Rachel A., et al.
Publicado: (2014)

Selectable Markers for Use in Genetic Manipulation of Extensively Drug-Resistant (XDR) Acinetobacter baumannii HUMC1
por: Luna, Brian M., et al.
Publicado: (2017)

Effect of Phenylalanine–Arginine Beta-Naphthylamide on the Values of Minimum Inhibitory Concentration of Quinolones and Aminoglycosides in Clinical Isolates of Acinetobacter baumannii
por: Plasencia-Rebata, Stefany, et al.
Publicado: (2023)

Effect of Efflux Pump Inhibitor Carbonyl Cyanide 3-Chlorophenylhydrazone on the Minimum Inhibitory Concentration of Ciprofloxacin in Acinetobacter baumannii Clinical Isolates
por: Ardebili, Abdollah, et al.
Publicado: (2014)

Active and Passive Immunization Protects against Lethal, Extreme Drug Resistant-Acinetobacter baumannii Infection
por: Luo, Guanpingshen, et al.
Publicado: (2012)

Isolation and Characterization of Acinetobacter baumannii Recovered from Campylobacter Selective Medium
por: Fernando, Dinesh M., et al.
Publicado: (2016)

A comprehensive and contemporary “snapshot” of β-lactamases in carbapenem resistant Acinetobacter baumannii
por: Hujer, Andrea M., et al.
Publicado: (2021)

Characterization of the Rifamycin-Degrading Monooxygenase From Rifamycin Producers Implicating Its Involvement in Saliniketal Biosynthesis
por: Zheng, Xiao-Fu, et al.
Publicado: (2020)

A Nutrient-limited Screen Unmasks Rifabutin Hyperactivity for XDR Acinetobacter baumannii
por: Luna, B., et al.
Publicado: (2020)

Effects of Sub-Minimum Inhibitory Concentrations of Imipenem and Colistin on Expression of Biofilm-Specific Antibiotic Resistance and Virulence Genes in Acinetobacter baumannii Sequence Type 1894
por: Shenkutie, Abebe Mekuria, et al.
Publicado: (2022)

Deciphering the late steps of rifamycin biosynthesis
por: Qi, Feifei, et al.
Publicado: (2018)

Developing an in silico minimum inhibitory concentration panel test for Klebsiella pneumoniae
por: Nguyen, Marcus, et al.
Publicado: (2018)

1113. Ceftazidime retains in vivo efficacy against strains of Stenotrophomonas maltophilia for which traditional testing predicts resistance
por: Phillips, Matthew C, et al.
Publicado: (2023)

Inhibitory Effect of Zinc Sulfate on Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii
por: Ramdas, Ishaan, et al.
Publicado: (2020)

1,2,3-Triazolylmethaneboronate: A Structure Activity Relationship Study of a Class of β-Lactamase Inhibitors against Acinetobacter baumannii Cephalosporinase
por: Caselli, Emilia, et al.
Publicado: (2020)

Tackling Acinetobacter baumannii
por: Granata, Guido, et al.
Publicado: (2023)

Dual infection with Acinetobacter baumannii and Klebsiella pneumoniae in a patient with multiple comorbidities – case presentation
por: Săndulescu, Oana, et al.
Publicado: (2014)

Cross-protection and cross-feeding between Klebsiella pneumoniae and Acinetobacter baumannii promotes their co-existence
por: Semenec, Lucie, et al.
Publicado: (2023)

Evaluation of DNA Extraction Methods for Reliable Quantification of Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa
por: Bogožalec Košir, Alexandra, et al.
Publicado: (2023)

Pharmacology, Dosing, and Side Effects of Rifabutin as a Possible Therapy for Antibiotic-Resistant Acinetobacter Infections
por: Phillips, Matthew C, et al.
Publicado: (2020)

Study on Dissolution Thermodynamics and Cooling Crystallization of Rifamycin S
por: Chen, Kui, et al.
Publicado: (2021)

Toward Repurposing Ciclopirox as an Antibiotic against Drug-Resistant Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae
por: Carlson-Banning, Kimberly M., et al.
Publicado: (2013)

Silver Nanostar-Based SERS for the Discrimination of Clinically Relevant Acinetobacter baumannii and Klebsiella pneumoniae Species and Clones
por: de Almeida, Miguel Peixoto, et al.
Publicado: (2023)

In Vitro Synergistic Activity of Antimicrobial Combinations against Carbapenem- and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae
por: Mantzana, Paraskevi, et al.
Publicado: (2023)

Inhibition of LpxC Protects Mice from Resistant Acinetobacter baumannii by Modulating Inflammation and Enhancing Phagocytosis
por: Lin, Lin, et al.
Publicado: (2012)

Multidrug-Resistant Acinetobacter baumannii
por: Abbo, Aharon, et al.
Publicado: (2005)

Multidrug-Resistant Acinetobacter baumannii
por: Krcmery, Vladimir, et al.
Publicado: (2007)

Diagnosis of Acinetobacter Baumannii Infections
por: Gozdas, Hasan T
Publicado: (2012)

Acinetobacter baumannii—The New MRSA?
por: Barrie, Alasdair, et al.
Publicado: (2016)

Glycosphingolipids Recognized by Acinetobacter baumannii
por: Madar Johansson, Miralda, et al.
Publicado: (2020)

Subunit vaccines for Acinetobacter baumannii
por: Yang, Ning, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hftgonrg0luurkgq4ldhiirat3